Metformin Improves Insulin Signaling in Obese Rats via Reduced IKKβ Action in a Fiber-Type Specific Manner
Metformin is a widely used insulin-sensitizing drug, though its mechanisms are not fully understood. Metformin has been shown to activate AMPK in skeletal muscle; however, its effects on the inhibitor of κB kinaseβ (IKKβ) in this same tissue are unknown. The aim of this study was to (1) determine th...
Saved in:
Main Authors: | Benjamin T. Bikman (Author), Donghai Zheng (Author), Daniel A. Kane (Author), Ethan J. Anderson (Author), Tracey L. Woodlief (Author), Jesse W. Price (Author), G. Lynis Dohm (Author), P. Darrell Neufer (Author), Ronald N. Cortright (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2010-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is There a Metabolic Program in the Skeletal Muscle of Obese Individuals?
by: Joseph A. Houmard, et al.
Published: (2011) -
Hvorfor velger ikke flere menn jordmoryrket?
by: Heidi Renberg, et al.
Published: (2022) -
Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
by: Jiali Gan, et al.
Published: (2023) -
IKK-mediated CYLD phosphorylation and cellular redox activity
by: Adnan Erol
Published: (2022) -
Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology
by: Qing-Ao Xiao, et al.
Published: (2022)